IRCT2016111827097N2已完成2 期
Effect of pentoxifylline as an intervention to reduce proteinuria in patients with type 2 of diabetes treated with angiotensin system blockers compared with patients (control group) were treated with ACEI or ARB
Ardebil University of Medical Sciences0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •patients with type 2 of diabetes; proteinuria greater than 500 mg per 24 hours; people who are treated with ACEI and ARB; patients who do not have contra-indications of PTX. Exclusion criteria: proteinuria less than 500 mg per 24 hours; people who had a history of retinal hemorrhages; who had a history of MI; patients who have contra-indications of PTX; those treated with ACEI and ARB not; people who have hypotension
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Effect of pentoxifylline on multiple sclerosis treatmentMULTIPLE SCLEROSIS.Multiple sclerosisIRCT201301148430N7euroscience Research center44
尚未招募
3 期
Investigation of the effect of pentoxifylline on Covid-19IRCT20170609034406N8Tabriz University of Medical Sciences100
尚未招募
3 期
Evaluation of the effect of pentoxifylline on the prevention of erythrocyte lysis in cardiac surgery patientsAll patients undergo open heart surgery.IRCT20210420051018N1Semnan University of Medical Sciences15
尚未招募
2 期
The effect of Pentoxifylline for the treatment of major depression in cardiovascular patientsIRCT20090117001556N132Tehran University of Medical Sciences50
已完成
2 期
Pentoxifylline effect in reduction of serum C-Reactive Protein (CRP) level in hemodialysis patients?End Stage Renal Disease.?End Stage Renal DiseaseIRCT138901293744N1Qazvin University of Medical Sciences66